Anti-Nephrin Antibodies in Focal Segmental Glomerulosclerosis Recurrence After Transplantation: A Multicenter Study from the TANGO Consortium
Authors:
- Marie-Camille LafargueMLMarie-Camille Lafargue
- Frank HullekesFHFrank Hullekes
- Juliette LeonJLJuliette Leon
- Rodrigo GassenRGRodrigo Gassen
- Suvra MitraSMSuvra Mitra
- Antonio M. FontanellaAFAntonio M. Fontanella
- Adela D. MattiazziAMAdela D. Mattiazzi
- George W. BurkeGBGeorge W. Burke
- Gianluca CaridiGCGianluca Caridi
Open Access
- 15 November 2026
- journal article
- Published by Elsevier in American Journal of Transplantation
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
- Congressionally Directed Medical Research Programs
This publication has 26 references indexed in Scilit:
- Antinephrin, Antipodocin, and Anti-Kirrel1 Autoantibodies in Posttransplant Recurrent FSGSKidney International Reports, 2026
- Co-localization of IgG with nephrin in immune-mediated idiopathic nephrotic syndromeClinical and Experimental Nephrology, 2025
- Non-invasive Diagnosis of Antinephrin–Associated PodocytopathyKidney International Reports, 2025
- Anti-nephrin antibodies in adult Chinese patients with minimal change disease and primary focal segmental glomerulosclerosisKidney International, 2025
- Detection of Antinephrin Antibodies in Childhood Idiopathic Nephrotic SyndromeKidney International Reports, 2024
- Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressantsKidney International, 2024
- Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograftKidney International, 2024
- Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statementsKidney International, 2023
- A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrenceKidney International, 2023
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular DiseasesKidney International, 2021